Simona Casalino

A phase II trial of the FGFR inhibitor pemigatinib in patients with metastatic esophageal–gastric junction/gastric cancer trastuzumab resistant: the FiGhTeR trial

Valeria Merz, Camilla Zecchetto, Francesca Simionato et al. · Therapeutic Advances in Medical Oncology · 2020 · 39 citations · Full text

Medicine, Oncology, Pharmacology +17

A Novel EGFRvIII T-Cell Bispecific Antibody for the Treatment of Glioblastoma

Raffaella Iurlaro, Inja Waldhauer, Ester Planas‐Rigol et al. · Molecular Cancer Therapeutics · 2022 · 33 citations · Full text

Medicine, Oncology, Pharmacology +17

Autotaxin Secretion Is a Stromal Mechanism of Adaptive Resistance to TGFβ Inhibition in Pancreatic Ductal Adenocarcinoma

Silvia Pietrobono, Fabio Sabbadini, Monica Bertolini et al. · Cancer Research · 2023 · 33 citations · Full text

Medicine, Oncology, Pharmacology +17

Organisational challenges, volumes of oncological activity and patients' perception during the severe acute respiratory syndrome coronavirus 2 epidemic

Serena Zuliani, Ilaria Zampiva, Daniela Tregnago et al. · European Journal of Cancer · 2020 · 31 citations · Full text

Medicine, Infectious Diseases, Oncology +13

The role of nanoliposomal irinotecan plus fluorouracil/leucovorin in the continuum of care of patients with metastatic pancreatic ductal adenocarcinoma

Letizia Procaccio, Valeria Merz, Morena Fasano et al. · Cancer Medicine · 2023 · 18 citations · Full text

Medicine, Oncology, Pharmacology +17